<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02857660</url>
  </required_header>
  <id_info>
    <org_study_id>FRANSO_2016_IMP</org_study_id>
    <nct_id>NCT02857660</nct_id>
  </id_info>
  <brief_title>Effect of Whole Body Electromyostimulation and/or Protein Supplementation on Sarcopenic Obesity in 70+</brief_title>
  <acronym>FRANSO</acronym>
  <official_title>Effect of Whole-body Electromyostimulation (WB-EMS) and/or Protein Supplementation on Sarcopenic Obesity in Community Dwelling Males 70+ With Sarcopenic Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Erlangen-Nürnberg Institute of Medical Physics</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Erlangen-Nürnberg Institute of Biomedicine of Aging</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to determine the effect of 16 weeks of Whole
      Body-Electromyostimulation (WB-EMS) and/or protein supplementation on Sarcopenic Obesity (SO)
      in community dwelling male subjects 70+ with SO .

      108 eligible men will be randomly assigned to either a (1) WB-EMS and Protein (2) Protein (3)
      sedentary control group.

      WB-EMS will be applied 1,5 x 20 min per week (i.e. 3 sessions in two weeks) with bipolar
      current, 85 Hz in an intermitted mode (4 s - 4 s of rest). Protein supplementation will be
      adjusted to dietary intake in order to reach a total protein intake between 1,5 - 1,7g/kg
      body-mass/d . Primary study endpoint will be the Sarcopenia Z-Score
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to evaluate the effects of Whole-Body Electromyostimulation (WB-EMS)
      with additional protein supplementation on Sarcopenic Obesity parameters in independently
      living men 70 years and older with sarcopenic obesity. The randomized controlled study
      compares three groups with 36 subjects each: (1) WB-EMS with additional protein
      supplementation, (2) protein-only and (3) passive control group, over a period of 16 weeks of
      WB-EMS -training. Group (1) conducts 1.5-times/week a 20 minute-sessions of WB-EMS with
      additional protein, group (2) is limited to protein supplementation (only) and group (3) is
      constrained to maintain their habitual living behavior and physical activity. Based on an
      individual nutrition analysis the protein intake will be adjusted to 1.5-1.7 g/kg/
      bodymass/d. All groups will be supplemented with a maximum of 800 IE Vitamin D.

      Primary study endpoint will be changes of the Sarcopenia Z-Score with skeletal muscle mass
      assessed via bio-impedance analysis (BIA). Secondary study endpoints are changes of Obesity
      (i.e. body-fat as assessed via BIA), cardiometabolic risk (i.e. Metabolic Syndrome Z-Score),
      strength parameters evaluated via Dr. Wolff BackCheck and Physiomed LegPress, quality of life
      (SF-12) and functional disability (late life physical disability index).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 2016</start_date>
  <completion_date type="Actual">April 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of Sarcopenia Z-Score</measure>
    <time_frame>Change from Baseline Sarcopenia Z-Score at 16 weeks</time_frame>
    <description>ie. Z-Score generated by skeletal muscle index, gait speed and grip-strength according to the Sarcopenia Definition of the European Working Group on Sarcopenia in Older People</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of Obesity</measure>
    <time_frame>Change from Baseline Obesity at 16 weeks</time_frame>
    <description>Assessment of body fat content and body mass index</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of Metabolic Syndrome Z-Score</measure>
    <time_frame>Change from Baseline Metabolic Syndrome Z-Score at 16 weeks</time_frame>
    <description>Metabolic Syndrome according to the International Diabetes Federation (IDF)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of isokinetic leg strength</measure>
    <time_frame>Change from Baseline isokinetic leg strength at 16 weeks</time_frame>
    <description>Dynamic strength of the leg extensors and flexors as determined by a isokinetic leg press</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Quality of Life</measure>
    <time_frame>Change from Baseline Quality of life at 16 weeks</time_frame>
    <description>Quality of life as determined by the SF-12 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Physical Disability</measure>
    <time_frame>Change from Baseline Physical Disability at 16 weeks</time_frame>
    <description>Physical disability as assessed by Late Life Functional and Disability Index (LLFDI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of Back Extensors Strength</measure>
    <time_frame>Change from Baseline Back Extensors Strength at 16 weeks</time_frame>
    <description>Strength of the back extensors and flexors using the Doctor Wolff Backcheck device</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Sarcopenic Obesity</condition>
  <arm_group>
    <arm_group_label>Whole-Body Electromyostimulation and Protein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>16 weeks of whole-body intervention 1.5 x 20 min week with bipolar current up to 1.5 - 1.7 g/kg body mass/d of protein supplements up to 800 IU/d Vitamin D-Supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Protein supplementation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>up to 1.5 - 1.7 g/kg body mass/d of protein supplements up to 800 IU/d Vitamin D-Supplementation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sedentary Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No protein supplementation or WB-EMS-application, but up to 800 IU/d Vitamin D-Supplementation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Whole body Electromyostimulation (exercise)</intervention_name>
    <description>1.5 x 20 min/week (e.g. each Tuesday and every second Friday) with bipolar current, 85 Hz, 360 µs, rectangular mode, intermittent with 4 sec of current and 4 s of rest.</description>
    <arm_group_label>Whole-Body Electromyostimulation and Protein</arm_group_label>
    <other_name>Electrostimulation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Protein</intervention_name>
    <description>up to 1.5-1.7 g/kg bodymass/d of protein (whey protein)</description>
    <arm_group_label>Whole-Body Electromyostimulation and Protein</arm_group_label>
    <arm_group_label>Protein supplementation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  community dwelling, independent living men

          -  Sarcopenia

          -  Obesity (body fat &gt;=25%)

        Exclusion Criteria:

          -  exclusion criteria for WB-EMS-application (e.g. cardiac pacemaker)

          -  diseases/medication that affect the study endpoints (e.g. Glucocorticoids &gt;5mg/d)

          -  absence of more than 2 weeks during the study period
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>70 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cornel Sieber, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Institute of Biomedicine of Aging, University of Erlangen-Nürnberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Klaus Engelke, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Erlangen-Nürnberg Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ellen Freiberger, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Institute of Biomedicine of Aging, University of Erlangen-Nürnberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Anja Weissenfels, MA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Erlangen-Nürnberg Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wolfgang Kemmler, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Erlangen-Nürnberg Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Medical Physics, Friedrich Alexander University Erlangen-Nürnberg</name>
      <address>
        <city>Erlangen</city>
        <state>Bavaria</state>
        <zip>91052</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kemmler W, Teschler M, Weissenfels A, Bebenek M, von Stengel S, Kohl M, Freiberger E, Goisser S, Jakob F, Sieber C, Engelke K. Whole-body electromyostimulation to fight sarcopenic obesity in community-dwelling older women at risk. Resultsof the randomized controlled FORMOsA-sarcopenic obesity study. Osteoporos Int. 2016 Nov;27(11):3261-3270. doi: 10.1007/s00198-016-3662-z. Epub 2016 Jun 12.</citation>
    <PMID>27289534</PMID>
  </reference>
  <reference>
    <citation>Kemmler W, Teschler M, Goisser S, Bebenek M, von Stengel S, Bollheimer LC, Sieber CC, Freiberger E. Prevalence of sarcopenia in Germany and the corresponding effect of osteoarthritis in females 70 years and older living in the community: results of the FORMoSA study. Clin Interv Aging. 2015 Oct 3;10:1565-73. doi: 10.2147/CIA.S89585. eCollection 2015.</citation>
    <PMID>26491272</PMID>
  </reference>
  <reference>
    <citation>Kemmler W, von Stengel S, Engelke K, Sieber C, Freiberger E. Prevalence of sarcopenic obesity in Germany using established definitions: Baseline data of the FORMOsA study. Osteoporos Int. 2016 Jan;27(1):275-81. doi: 10.1007/s00198-015-3303-y. Epub 2015 Aug 29.</citation>
    <PMID>26318759</PMID>
  </reference>
  <reference>
    <citation>Goisser S, Kemmler W, Porzel S, Volkert D, Sieber CC, Bollheimer LC, Freiberger E. Sarcopenic obesity and complex interventions with nutrition and exercise in community-dwelling older persons--a narrative review. Clin Interv Aging. 2015 Aug 6;10:1267-82. doi: 10.2147/CIA.S82454. eCollection 2015. Review.</citation>
    <PMID>26346071</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2016</study_first_submitted>
  <study_first_submitted_qc>August 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 5, 2016</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 2, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sarcopenia</keyword>
  <keyword>Obesity</keyword>
  <keyword>Whole-Body Electromyostimulation</keyword>
  <keyword>Protein Supplementation</keyword>
  <keyword>community dwelling men</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

